Atlas Trials

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Clinical trial NCT02249949 · COMPLETED

Trial details

NCT number
NCT02249949
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Liposarcoma
Start date
2015-02-11
Primary completion
2018-10-04
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.